Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 11, Number 6—June 2005


Antimicrobial Resistance Determinants and Future Control

Stephan Harbarth*Comments to Author  and Matthew H. Samore†
Author affiliations: *University of Geneva Hospitals, Geneva, Switzerland; †VA Salt Lake City Health Care System, Salt Lake City, Utah, USA

Main Article

Table 3

Proportions of appropriate perioperative antimicrobial drug prophylaxis in Belgian hospitals after change in the reimbursement system*

1986 (%) 1999 (%)
Correct timing 53 70
Correct indication 92 97
Duration >48 h 50 8
Choice of agent
First-generation cephalosporin 28 66
Second-generation cephalosporin 17 29

*Source: Goossens et al (34).

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO